Aquanaz

Manufacturer
Capital Pharmaceutical, LLC
Effective date
2020-08-21
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 23:16:36

Label at a glance#

ProductAquanaz PSE
Active ingredientDEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE
Label structure12 sections

Indications and uses

Temporarily relieves these symptoms occurring with a cold nasal decongestion: ▪ cough due to minor throat and bronchial irritation ▪ helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes.

Dosage and administration

Adults and children 12 years of age and over 1 tablet every 4 hours, not to exceed 4 tablets in 24 hours, or as directed by a doctor. Children 6 to under 12 years of age 1/2 tablet every 4 hours, not to exceed 2 tablets in 24 hours, or as directed by a doctor. Do not exceed recommended dosage.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Dextromethorphan HBr 20mg

Guaifenesin 375mg

Pseudoephedrine HCl 60mg

Purpose

OTC - PURPOSE SECTION

Cough Suppressant

Expectorant

Nasal Decongestant

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves these symptoms occurring with a cold nasal decongestion:
▪ cough due to minor throat and bronchial irritation
▪ helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes.

Warnings

WARNINGS SECTION

▪ When using this product do not exceed recommended dosage.

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs

for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2
weeks after stopping the MAOI drug. If you do not know if your prescription drug
contains an MAOI, ask a doctor or pharmacist before taking this product.

Stop use and ask doctor if

OTC - STOP USE SECTION


▪ symptoms do not improve
▪ new symptoms occur
▪ redness or swelling is present
▪ nervousness, dizziness, or sleeplessness occur
▪ symptoms do not improve within 7 days or are accompanied by fever
▪ cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or
persistent headache. A persistent cough may be a sign of a serious condition.

Ask Doctor before use if you have

OTC - ASK DOCTOR SECTION

▪ heart disease
▪ high blood pressure
▪ thyroid disease
▪ diabetes
▪ difficulty in urinating due to enlargement of the prostate gland
▪ persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or
emphysema or where cough is accompanied by excessive phlegm

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age
and over
1 tablet every 4 hours, not to
exceed 4 tablets in 24 hours, or as
directed by a doctor.


Children 6 to under 12 years of age
1/2 tablet every 4 hours, not to
exceed 2 tablets in 24 hours, or as
directed by a doctor.

Do not exceed recommended dosage.

Pregnant or Breast Feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding, ask a health professional before use.

Keep out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away. Prompt
medical attention is critical for adults as well as children even if you do not notice any signs or
symptoms

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Carnauba Wax, FD&C Blue #1 Aluminum Lake, FD&C Yellow #5 Aluminum Lake, Magnesium
Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Polysorbate 80, Polyvinyl Alcohol,
Silicon Dioxide, Talc

Other information

SPL UNCLASSIFIED SECTION

Store at 15°-30°C (59°-86°F).

  • Aquanaz PSE is a clear coated caplet with green core, debossed with “AQ” Bisection “PSE” on

one side and smooth on the other side.

  • Contains color additives including FD&C Yellow No. 5 (tartrazine).
  • Supplied in a tight, light-resistant container with a child-resistant cap.
  • Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.
  • Store at Controlled Room Temperature 15°-30°C (59°-86°F).


Questions? Comments
Call 1(614) 638-4622

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 29978-588-90


Aquanaz PSE Tablets
Triple Combination Relief:
Cough Suppressant: Dextromethorphan HBr 20 mg
Expectorant: Guaifenesin 375 mg
Nasal Decongestant: Pseudoephedrine HCI 60 mg
90 tablets labellabel

backback

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
29978-588-90EA - Each29978-588fde4a999-369e-4924-9aea-d0e7072b1e6112021-01-08

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
29978-58829978-588-90

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0dfa2992-cb91-c26b-e063-6394a90ae96da50074cd-d830-ca26-e053-2a95a90a6bc92024-01-02WarningsExact identifier
spl set id: a50074cd-d830-ca26-e053-2a95a90a6bc9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.